A237690 Stock Overview
Provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
ST Pharm Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩86,900.00 |
| 52 Week High | ₩112,700.00 |
| 52 Week Low | ₩59,900.00 |
| Beta | 0.65 |
| 11 Month Change | -6.86% |
| 3 Month Change | -2.14% |
| 1 Year Change | 12.86% |
| 33 Year Change | -23.97% |
| 5 Year Change | 409.68% |
| Change since IPO | 78.07% |
Recent News & Updates
Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?
May 09
Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem
Mar 22Recent updates
Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?
May 09Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem
Mar 22ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected
Mar 18Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%
Mar 16Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)
Jan 22What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?
Dec 23Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?
Nov 26
Shareholder Returns
| A237690 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -6.5% | -1.7% | -0.6% |
| 1Y | 12.9% | 5.9% | 6.8% |
Return vs Industry: A237690 exceeded the KR Pharmaceuticals industry which returned 5.9% over the past year.
Return vs Market: A237690 exceeded the KR Market which returned 6.8% over the past year.
Price Volatility
| A237690 volatility | |
|---|---|
| A237690 Average Weekly Movement | 9.0% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.1% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A237690's share price has been volatile over the past 3 months.
Volatility Over Time: A237690's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 627 | Peter Kim | www.stpharm.co.kr |
ST Pharm Co.,Ltd., provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical R and D solutions.
ST Pharm Co.,Ltd. Fundamentals Summary
| A237690 fundamental statistics | |
|---|---|
| Market cap | ₩1.69t |
| Earnings (TTM) | ₩22.03b |
| Revenue (TTM) | ₩286.07b |
76.8x
P/E Ratio5.9x
P/S RatioIs A237690 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A237690 income statement (TTM) | |
|---|---|
| Revenue | ₩286.07b |
| Cost of Revenue | ₩182.47b |
| Gross Profit | ₩103.60b |
| Other Expenses | ₩81.57b |
| Earnings | ₩22.03b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.13k |
| Gross Margin | 36.22% |
| Net Profit Margin | 7.70% |
| Debt/Equity Ratio | 46.2% |
How did A237690 perform over the long term?
See historical performance and comparison